Status:
COMPLETED
Optical Coherence Tomography Guided Percutaneous Coronary Intervention With Stent Implantation
Lead Sponsor:
Odense University Hospital
Conditions:
Coronary Artery Disease
Myocardial Infarction
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Coronary artery disease is one of the most prevalent diseases in the western countries. A waxy substance called plaque can build up inside the coronary arteries. Over time, plaque can harden or ruptu...
Detailed Description
Drug-eluting stents (DES) have reduced the rate of in-stent restenosis dramatically in comparison with bare-metal stents (BMS). Still, there are "safety concerns" in form of late and very late stent t...
Eligibility Criteria
Inclusion
- A Non ST segment Elevation Myocardial Infarction (NSTEMI) had been diagnosed
- A de novo lesion (more than or equal to 50% dimater stenosis) had been visualized on coronary angiography
- A Percutaneous Coronary Intervention with Drug-Eluting Stent (DES) implantation was indicated
Exclusion
- Patients included in other randomized trials
- Lifeexpectancy \<1 year
- Allergy to aspirin, clopidogrel, ticagrelor and prasugrel
- Allergy to limus-agents
- Ostial lesions (not possible to flush by OCT)
- S-creatinin \>170 micrograms/l
- Tortuous and extremely calcified lesions where intravascular imaging is deemed associated with an increased risk for the patient
- Very long lesions (due to the limited pullback length of the OCT system)
Key Trial Info
Start Date :
August 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2014
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT02272283
Start Date
August 1 2011
End Date
May 1 2014
Last Update
October 22 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.